8 Penny Stocks on Fire – BRN, EXU, FNT, AMG, JDR, TTW, FOD and NHL

penny stocks

Penny stocks are small micro-cap stocks which may be trading at less than a $1 price, and to pick the right company among these penny stocks it becomes very critical to assess future growth, operating potential and how you want to shape up the portfolio. Here are few penny stocks that have lately gained traction based on some key developments:

BRAINCHIP HOLDINGS LTD (ASX: BRN) – The company has technological development of design segment on SNAP i.e. spiking neuron adaptive processor and bring its production to the market. The Stock traded at a market price of $0.180 as at Sep 10, 2018. The company has seen a performance change of -8.57% over the past 12 months. Recently, announced by BrainChip Holdings Ltd. which is a leading neuromorphic computing company is the availability of the Akida Development Environment. The revenue from continuing operations had a percentage change of 279% from $133,302 in FY 17 to $505,001 in FY 18. During the year ended June 30, 2018 no dividends were paid or declared as the group made a net loss after income tax of $8,770,180. The total cash and cash equivalents at the end of the period June 30, 2018 was of US $11,892,002 while the company held the balance sheet as debt free status. The price to book value ratio of the company is well above 1 at 7.85 indicating high levels but at the same time, the stock still has immense potential given the assets under development.

EXPLAURUM LIMITED (ASX: EXU) – Ramelius Resources Limited is making an all scrip takeover offer for ordinary shares in Explaurum of 1 Ramelius Share for every 4 Explaurum shares. The total cash and cash equivalents at the end of the period June 30, 2018 was of $3.4 million while the company held the balance sheet as debt free status. The group has a negative earnings per share of -0.004 AUD. In the last one year, the stock has noted a performance change of -53.75%. The company had a free cashflow of A$ 151 million. With decent financial position company saw a daily price change of 41.892% as at September 10, 2018, the stock peaked at a market price of $0.105. The price to book value ratio of the company is above 1 at 1.87, indicating the company is slightly overvalued. [optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

FRONTIER RESOURCES LIMITED (ASX: FNT) – Frontier recently announced that the A$6,000,000 Placement Agreement with Forise Investments Sydney Pty Ltd (Forise) had been completed that was approved by shareholders at the Extraordinary General Meeting held on 15 May 2018. The revenue of the company decreased from $72,000 in FY 17 to $20,000 in 1H 18. The total comprehensive loss as observed in 1H 2018 was of ($476,000). As at September 10, 2018, the stock peaked at a market price of $0.016. In the last one year, the stock has noted a performance change of -42.86%. The total cash and cash equivalents at the end of the period June 30, 2018 was of $49,000 while the company held the balance sheet as debt free status. The price to book value ratio of the company is quite below 1 at -5.26.

AUSMEX MINING GROUP LIMITED (ASX: AMG) – The total cash and cash equivalents at the end of the period June 30, 2018 was of $2.077 million. In the last one year, the stock has noted a performance change of -38.10%. From the 100% owned, ‘The Trump’ granted Mining Lease ML2549 within AMG’s suite of Cloncurry, Queensland assets, Ausmex Mining Group has announced exceptional RC drilling results. Including a 6m gold zone within oxide material from 75 – 81m, averaging over 1 Ounce per ton of Gold, Bonanza gold grades were intersected in the extension of drill hole TR17RC07 with grades of up to 172 g/t gold. As at September 10, 2018, the stock peaked at a market price of $0.041. The price to book value ratio of the company is above 1 at 3.84, the company’s value looks to be on a higher side.

JADAR LITHIUM LIMITED (ASX: JDR) – The group’s first Pass sampling and mapping activities on Vranje-South Project now define Li-B anomalies. The company has indicated for completion of its preliminary field program on its 100% owned Rekovac project in Serbia. The renaissance sampling phase 1 has now completed on all 5 of the company’s 100% owned projects based in Serbia. The results are expected shortly, and it will provide updates once the results have been analyzed. As at the end of quarter June 30, 2018, cash and cash equivalents are of $3.41 million. In the last one year, the stock has noted a performance change of -57.14%. However, as at September 10, 2018, the stock went up at a market price of $0.014 which is near its 52-week low. The price to book value ratio of the company is below 1 at 0.04.

TOPTUNG LTD (ASX: TTW) – The company recently announced the identification of important historical gold results from its Lorraine Property in south-west Quebec, Canada. With ~$4.25million in cash to drill its highly prospective advanced projects, the Company will remain well positioned. Since the end of the previous financial period, no dividends have been paid or declared by the company and no dividend will be paid for the current financial year. This may be due to the net operating loss of $712,708 in 2018 compared against $356,915 in 2017. As at September 10, 2018, the stock went up at a market price of $0.053 with a percentage change of 8.163%. In the last one year, the stock has noted a performance change of 63.33%. The price to book value ratio of the company is above 1 at 1.20.

THE FOOD REVOLUTION GROUP LIMITED (ASX: FOD) – It is one of the largest functional food and beverage companies in Australia. The company reported a NPAT increase of 52% to $2.7 million. The company increased it yields and revenue through innovation. Driven by branded product sales and distribution, net sales are up by 5%. After provision for impairment of assets $0.86M, the EBITDA was of $3.8 million. Also, net assets increased 100% from $10 million to $20 million. Due to different product mix and wider product portfolio and sale of LTC, the gross margin is healthy at 38%. As at September 10, 2018, the stock went up at a market price of $0.100 with a percentage change of 23.457%. In the last one year, the stock has noted a performance change of 35.00%. The price to book value ratio of the company is above 1 at 1.04.

NOVITA HEALTHCARE LIMITED (ASX: NHL) – The company’s revenue from continuing operations changed only 2% from $566,156 in FY 17 to $557,291 in FY 18. However, due to the loss the earnings per share declined further from (0.73) cents to (1.35) cents. As at the end of the previous financial period, no dividends have been paid or declared by the company and no dividend will be paid for the current financial year. EBITDA has gone down further from ($1.22) million to ($4.037) million. The total cash and cash equivalents at the end of the period June 30, 2018 was of US $1.201 million while the company held the balance sheet as debt free status. As at September 10, 2018, the stock went up at a market price of $0.040 with a percentage change of 21.212%. In the last one year, the stock has noted a performance change of 22.22%. The price to book value ratio of the company is above 1 at 4.46, which is comparable to industry median of 12.01.

While most of the above stocks are coming into limelight based on key developments and progress on various projects, only a few to the likes of Brainchip have indication of rise in earnings per share as estimated by market consensus for the next fiscal year. It will be key to watch price movements for the above in the upcoming days.


Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report